找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Bladder Cancer; A Practical Guide Ashish M. Kamat,Peter C. Black Book 2021 Springer Nature Switzerland AG 2021 TURBT.Adjvuant Intravescial

[復(fù)制鏈接]
樓主: 小缺點
41#
發(fā)表于 2025-3-28 16:09:36 | 只看該作者
42#
發(fā)表于 2025-3-28 21:42:03 | 只看該作者
43#
發(fā)表于 2025-3-29 01:15:16 | 只看該作者
Transurethral Resection of Bladder Tumors (TURBT)surgery has been shown to have a significant impact on oncologic outcome. Imaging techniques such as blue light cystoscopy have been proven to further improve detection rates and oncologic outcomes. The impact of en bloc resection on recurrence and progression rates is currently under investigation.
44#
發(fā)表于 2025-3-29 04:58:08 | 只看該作者
45#
發(fā)表于 2025-3-29 09:00:32 | 只看該作者
46#
發(fā)表于 2025-3-29 15:09:19 | 只看該作者
Adjuvant Intravesical Chemotherapy. 68:7–30, 2018) About 75% of these newly diagnosed cases are nonmuscle-invasive bladder cancer (NMIBC). With such a large percentage of all bladder cancer patients having nonmuscle-invasive disease at diagnosis, it is fitting that the American Urological Association has a guideline specifically add
47#
發(fā)表于 2025-3-29 16:08:16 | 只看該作者
Device-Assisted Therapies for Nonmuscle-Invasive Bladder Cancer: A Practical Approach(NMIBC) or in the case of limited supply of conventional drugs. Device-assisted therapy can be done with hyperthermia or an electrical current. Based on (limited) published literature and personal experience, three methods of device-assisted therapy, which are currently mostly used in clinical trial
48#
發(fā)表于 2025-3-29 22:42:58 | 只看該作者
Intravesical Salvage Therapy After BCG/Regular Chemoy is the mainstay of frontline therapy; however, recurrence will still occur for 40–80% of patients over a 10-year period. Radical cystectomy with urinary diversion remains the standard of care for many of these patients; however, recent evidence suggests that this is underutilized as many patients
49#
發(fā)表于 2025-3-30 01:49:48 | 只看該作者
Oncological Monitoring of NonMuscle Invasive Bladder Cancer (NMIBC) cancer (NMIBC) comprises the majority of these cases and is known for its varying oncological outcomes and need for frequent follow-up and treatment. However, there is significant heterogeneity between surveillance protocols and an undefined role for the implementation of new endoscopic technology
50#
發(fā)表于 2025-3-30 06:54:36 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 15:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
鲁山县| 高安市| 兴城市| 昌邑市| 天台县| 肥西县| 纳雍县| 兴业县| 昌邑市| 通化县| 泸水县| 长垣县| 莱西市| 泽库县| 乐至县| 渝中区| 曲沃县| 龙南县| 高碑店市| 蒙山县| 吕梁市| 昌都县| 芜湖县| 三穗县| 衡南县| 泰顺县| 铁岭县| 洛南县| 鄂尔多斯市| 潜江市| 平泉县| 邻水| 公安县| 亳州市| 大宁县| 科尔| 繁峙县| 鹤庆县| 靖宇县| 林西县| 玉溪市|